Skip to content

Oral Paracetamol Versus Oral Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Infants: A Randomised Controlled Trial

Oral Paracetamol Versus Oral Ibuprofen Treatment

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01536158
Enrollment
80
Registered
2012-02-20
Start date
2012-02-29
Completion date
2012-12-31
Last updated
2012-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patent Ductus Arteriosus

Keywords

Patent Ductus Arteriosus, Paracetamol, Ibuprofen, Preterm infant

Brief summary

The purpose of this study is to determine whether oral paracetamol or ibuprofen has a better or same efficacy and tolerance in closure of patent ductus arteriosus in preterm infants.

Detailed description

To determine whether oral paracetamol or ibuprofen has a better or same efficacy and tolerance in closure of patent ductus arteriosus in preterm infants. Eighty preterm infants with patent ductus arteriosus will be enrolled in this prospective-randomized study. Patients will receive oral ibuprofen at an initial dose of 10 mg/kg, followed by 5 mg/kg at 24 and 48 h or oral paracetamol 15 mg/kg per dose every 6 hours. One of the following echocardiographic criteria of a duct size \>1.5 mm, a left atrium-to-aorta ratio \>1.5, left-to-right shunting of blood, end diastolic reversal of blood flow in the aorta, or poor cardiac function in addition signs of patent ductus arteriosis determined the need of treatment.

Interventions

Patients will receive oral paracetamol 15 mg/kg per dose every 6 hours for 3 days.

Patients will receive oral ibuprofen at an initial dose of 10 mg/kg, followed by 5 mg/kg at 24 and 48 h.

Sponsors

Zekai Tahir Burak Women's Health Research and Education Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
2 Days to 10 Days
Healthy volunteers
No

Inclusion criteria

* Birth weight below 1250 gram * Diagnosed patent ductus arteriosus by Echocardiographic examination

Exclusion criteria

* Accompanied other congenital cardiac anomalies * Urine output of less than 1 ml/kg/h during the preceding 8 h, * Serum creatinine level \>1.6 mg/dl, * Platelet count \<60,000/mm3, * Liver failure, * Hyperbilirubinemia requiring exchange transfusion * Severe intracranial bleeding (Grade III - IV) * Intestinal abnormality and necrotising enterocolitis

Design outcomes

Primary

MeasureTime frameDescription
Efficacy and Safety of Oral Paracetamol Versus Oral IbuprofenUntil dischargeTo compare the closure rate of patent ductus arteriosus after oral paracetamol or oral ibuprofen treatment

Secondary

MeasureTime frameDescription
Long term effects of oral paracetamol versus oral ibuprofen treatment in preterm infantscorrected 36 weeks or until dischargeLong term effects such as ROP, BPD,IVH, duration of respiratory support and hospitalization are going to be evaluated.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026